Peanut Oral Immunotherapy (OIT) - Initial Pilot Study in Adults
Status:
Terminated
Trial end date:
2015-11-01
Target enrollment:
Participant gender:
Summary
The goal of this study is to produce a new treatment that would benefit adult subjects by
lowering the risk of anaphylactic reactions (desensitization), and changing the
peanut-specific immune response in subjects who have peanut allergy (tolerance). This project
is designed to study the innovative idea that oral immunotherapy (OIT), the ingestion of
small increasing amounts of food allergen, will desensitize subjects with peanut
hypersensitivity by regulating their mucosal and systemic immune reactivity and cause
long-term tolerance.